B-cell prolymphocytic leukemia: Difference between revisions

	WikiDoc Resources for B-cell prolymphocytic leukemia
Articles
Most recent articles on B-cell prolymphocytic leukemia Most cited articles on B-cell prolymphocytic leukemia Review articles on B-cell prolymphocytic leukemia Articles on B-cell prolymphocytic leukemia in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on B-cell prolymphocytic leukemia Images of B-cell prolymphocytic leukemia Photos of B-cell prolymphocytic leukemia Podcasts & MP3s on B-cell prolymphocytic leukemia Videos on B-cell prolymphocytic leukemia
Evidence Based Medicine
Cochrane Collaboration on B-cell prolymphocytic leukemia Bandolier on B-cell prolymphocytic leukemia TRIP on B-cell prolymphocytic leukemia
Clinical Trials
Ongoing Trials on B-cell prolymphocytic leukemia at Clinical Trials.gov Trial results on B-cell prolymphocytic leukemia Clinical Trials on B-cell prolymphocytic leukemia at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on B-cell prolymphocytic leukemia NICE Guidance on B-cell prolymphocytic leukemia NHS PRODIGY Guidance FDA on B-cell prolymphocytic leukemia CDC on B-cell prolymphocytic leukemia
Books
Books on B-cell prolymphocytic leukemia
News
B-cell prolymphocytic leukemia in the news Be alerted to news on B-cell prolymphocytic leukemia News trends on B-cell prolymphocytic leukemia
Commentary
Blogs on B-cell prolymphocytic leukemia
Definitions
Definitions of B-cell prolymphocytic leukemia
Patient Resources / Community
Patient resources on B-cell prolymphocytic leukemia Discussion groups on B-cell prolymphocytic leukemia Patient Handouts on B-cell prolymphocytic leukemia Directions to Hospitals Treating B-cell prolymphocytic leukemia Risk calculators and risk factors for B-cell prolymphocytic leukemia
Healthcare Provider Resources
Symptoms of B-cell prolymphocytic leukemia Causes & Risk Factors for B-cell prolymphocytic leukemia Diagnostic studies for B-cell prolymphocytic leukemia Treatment of B-cell prolymphocytic leukemia
Continuing Medical Education (CME)
CME Programs on B-cell prolymphocytic leukemia
International
B-cell prolymphocytic leukemia en Espanol B-cell prolymphocytic leukemia en Francais
Business
B-cell prolymphocytic leukemia in the Marketplace Patents on B-cell prolymphocytic leukemia
Experimental / Informatics
List of terms related to B-cell prolymphocytic leukemia

	B-cell prolymphocytic leukemia
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating B-cell prolymphocytic leukemia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Biopsy
X Ray
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
B-cell prolymphocytic leukemia On the Web
Most recent articles
cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of B-cell prolymphocytic leukemia All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on B-cell prolymphocytic leukemia
CDC on B-cell prolymphocytic leukemia
B-cell prolymphocytic leukemia in the news
Blogs on B-cell prolymphocytic leukemia
Directions to Hospitals Treating B-cell prolymphocytic leukemia
Risk calculators and risk factors for B-cell prolymphocytic leukemia

VisualWikitext

Latest revision as of 16:33, 1 April 2019

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Qurrat-ul-ain Abid, M.D.[2], Carlos A Lopez, M.D. [3]

Synonyms and keywords: B-PLL, Prolymphocytic leukemia, B-cell type

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating B-cell prolymphocytic leukemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Treatment

References

Template:Jb1

Template:WikiDoc Sources

@@ Line 1: / Line 1: @@
 __NOTOC__
+{{B-cell prolymphocytic leukemia}}
 {{SI}}
-{{CMG}}
+{{CMG}}; {{AE}}{{Qurrat}}, {{CLG}}
-==Overview==
+{{SK}} B-PLL, Prolymphocytic leukemia, B-cell type
-'''B-cell prolymphocytic leukemia''' is a more aggressive but still treatable form of [[chronic lymphocytic leukemia]].  The malignant [[B cells]] are larger than average.  The name is commonly abbreviated B-PLL.
-==Pathophysiology==
+==[[B-cell prolymphocytic leukemia overview|Overview]]==
-It is postulated that the originating cell line for this disease is a mature B-cell. Due to the systemic nature of this disease, leukemic cells can be found in peripheral blood, lymph nodes, bone marrow, spleen, liver, skin.
-===Genetics===
+==[[B-cell prolymphocytic leukemia historical perspective|Historical Perspective]]==
-It can involve deletions from [[chromosome 11]] and [[chromosome 13]].<ref name="pmid10720137">{{cite journal |author=Lens D, Matutes E, Catovsky D, Coignet LJ |title=Frequent deletions at 11q23 and 13q14 in B cell prolymphocytic leukemia (B-PLL) |journal=Leukemia |volume=14 |issue=3 |pages=427-30 |year=2000 |pmid=10720137 |doi=}}</ref>
-===Markers===
+==[[B-cell prolymphocytic leukemia classification|Classification]]==
-*A case has been described as [[CD20]]+, [[CD22]]+, and [[CD5 (protein)|CD5]]-.<ref name="pmid9657013">{{cite journal |author=Yamamoto K, Hamaguchi H, Nagata K, Shibuya H, Takeuchi H |title=Splenic irradiation for prolymphocytic leukemia: is it preferable as an initial treatment or not? |journal=Jpn. J. Clin. Oncol. |volume=28 |issue=4 |pages=267–9 |date=April 1998 |pmid=9657013 |doi= 10.1093/jjco/28.4.267|url=http://jjco.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=9657013}}</ref>
-*It can also be CD5+.<ref name="urlPathology">{{cite web |url=http://www.med-ed.virginia.edu/courses/path/innes/wcd/lympleuk.cfm |title=Pathology |format= |work= |accessdate=2009-01-31| archiveurl= http://web.archive.org/web/20090207235133/http://www.med-ed.virginia.edu/courses/path/innes/wcd/lympleuk.cfm| archivedate= 7 February 2009 <!--DASHBot-->| deadurl= no}}</ref>
-*Another case was described as [[CD45]]+, [[CD19]]+, [[CD20]]+, [[CD5]]+, [[HLA-DR]]+, [[CD10]]-, [[CD23]]+/-, [[CD38]]+ and [[FMC7]]-.<ref name="pmid16997373">{{cite journal |author=Crisostomo RH, Fernandez JA, Caceres W |title=Complex karyotype including chromosomal translocation (8;14) (q24;q32) in one case with B-cell prolymphocytic leukemia |journal=Leuk. Res. |volume=31 |issue=5 |pages=699–701 |date=May 2007 |pmid=16997373 |doi=10.1016/j.leukres.2006.06.010 |url=http://linkinghub.elsevier.com/retrieve/pii/S0145-2126(06)00218-9}}</ref>
-==Prognosis==
+==[[B-cell prolymphocytic leukemia pathophysiology|Pathophysiology]]==
-It has a relatively poor prognosis.<ref name="pmid16642047">{{cite journal |author=Del Giudice I, Davis Z, Matutes E, ''et al'' |title=IgVH genes mutation and usage, [[ZAP-70]] and [[CD38]] expression provide new insights on B-cell prolymphocytic leukemia (B-PLL) |journal=Leukemia |volume=20 |issue=7 |pages=1231-7 |year=2006 |pmid=16642047 |doi=10.1038/sj.leu.2404238}}</ref>
-==Differential Diagnosis==
+==[[B-cell prolymphocytic leukemia causes|Causes]]==
-* Hairy cell leukemia<ref name="pmid19110524">{{cite journal |author=Nakashima H, Saito B, Ariizumi H, Matsuda I, Nakamaki T, Tomoyasu S |title=Splenic irradiation as a successful treatment for an elderly patient with B-cell prolymphocytic leukemia |journal=Rinsho Ketsueki |volume=49 |issue=12 |pages=1619–22 |date=December 2008 |pmid=19110524 |doi=10.11406/rinketsu.49.1619}}</ref>
-* Waldenström macroglobulinemia<ref name="pmid19110524">{{cite journal |author=Nakashima H, Saito B, Ariizumi H, Matsuda I, Nakamaki T, Tomoyasu S |title=Splenic irradiation as a successful treatment for an elderly patient with B-cell prolymphocytic leukemia |journal=Rinsho Ketsueki |volume=49 |issue=12 |pages=1619–22 |date=December 2008 |pmid=19110524 |doi=10.11406/rinketsu.49.1619}}</ref>
+==[[B-cell prolymphocytic leukemia differential diagnosis|Differentiating B-cell prolymphocytic leukemia from other Diseases]]==
+==[[B-cell prolymphocytic leukemia epidemiology and demographics|Epidemiology and Demographics]]==
+==[[B-cell prolymphocytic leukemia risk factors|Risk Factors]]==
+==[[B-cell prolymphocytic leukemia screening|Screening]]==
+==[[B-cell prolymphocytic leukemia natural history, complications and prognosis|Natural History, Complications and Prognosis]]==
+==Diagnosis==
+[[B-cell prolymphocytic leukemia history and symptoms|History and Symptoms ]] | [[ B-cell prolymphocytic leukemia physical examination|Physical Examination]] | [[B-cell prolymphocytic leukemia laboratory findings|Laboratory Findings]] | [[ B-cell prolymphocytic leukemia biopsy|Biopsy]] | [[B-cell prolymphocytic leukemia CT|CT ]] | [[B-cell prolymphocytic leukemia MRI|MRI]] | [[B-cell prolymphocytic leukemia other imaging findings|Other Imaging Findings]] | [[B-cell prolymphocytic leukemia other diagnostic studies|Other Diagnostic Studies]]
 ==Treatment==
-*Splenic irradiation has been used in the treatment.<ref name="pmid19110524">{{cite journal |author=Nakashima H, Saito B, Ariizumi H, Matsuda I, Nakamaki T, Tomoyasu S |title=Splenic irradiation as a successful treatment for an elderly patient with B-cell prolymphocytic leukemia |journal=Rinsho Ketsueki |volume=49 |issue=12 |pages=1619–22 |date=December 2008 |pmid=19110524 |doi=10.11406/rinketsu.49.1619}}</ref>
+[[B-cell prolymphocytic leukemia medical therapy|Medical Therapy]] | [[B-cell prolymphocytic leukemia surgery|Surgery]] | [[B-cell prolymphocytic leukemia primary prevention|Primary Prevention]] | [[B-cell prolymphocytic leukemia secondary prevention|Secondary Prevention]] | [[B-cell prolymphocytic leukemia cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[B-cell prolymphocytic leukemia future or investigational therapies|Future or Investigational Therapies]]
-*Cladribine (2-chlorodeoxyadenosine) appears to be an active agent (60% complete remission rate) for patients with de novo B-cell prolymphocytic leukemia.<ref name=B-CellPLl>{{cite web | title = National Cancer Institute| url =http://www.cancer.gov/types/leukemia/hp/cll-treatment-pdq}}</ref>
 ==References==

v t e Myeloid Hematological malignancy/leukemia histology (ICD-O 9590-9989, C81-C96, 200-208)
CFU-GM/ and other granulocytes	Template:Navbox subgroup
MEP	Template:Navbox subgroup
CFU-Mast	Mastocytoma (Mast cell leukemia, Mast cell sarcoma, Systemic mastocytosis)
Multiple/unknown	AML (Acute panmyelosis with myelofibrosis, Myeloid sarcoma) · MP (Myelofibrosis) · Acute biphenotypic leukaemia
See also hematology, lymphoid malignancy

B-cell prolymphocytic leukemia: Difference between revisions

Latest revision as of 16:33, 1 April 2019

Diagnosis

Treatment

References

Navigation menu